Ronald McCarthy

Ronald McCarthy

Auto-generated profile, based on publicly available information

Ronald McCarthy

Department of Obstetrics and Gynecology, Center for Reproductive Health Sciences, Washington University School of Medicine, St. Louis, Missouri

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2018 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
RMRonald McCarthy
Ronald McCarthy
CMCarmel Martin-Fairey
Carmel Martin-Fairey
DSDorothy K Sojka
Dorothy K Sojka
EHErik D Herzog
Erik D Herzog
EJEmily S Jungheim
Emily S Jungheim
SESarah K England
Sarah K England
Preterm birth affects approximately 1 out of every 10 births in the United States, leading to high rates of mortality and long-term negative health consequences. To investigate the mechanisms leading to preterm birth so as to develop prevention strategies, researchers have developed numerous mouse models of preterm birth. However, the lack of standard definitions for preterm birth in mice limits our field's ability to compare models and make inferences about preterm birth in humans. In this review, we discuss numerous mouse preterm birth models, propose guidelines for experiments and reporting, and suggest markers that can be used to assess whether pups are premature or mature. We argue that adoption of these recommendations will enhance the utility of mice as models for preterm birth.

10 April 2026 in Journal of Biological Rhythms
Verified
Journal Article
Closed access
KNK. L. Nikhil
K. L. Nikhil
KBKeenan Bates
Keenan Bates
ESElizabeth Sapiro
Elizabeth Sapiro
JAJacob L. Amme
Jacob L. Amme
RMRon McCarthy
Ron McCarthy
EHErik D. Herzog
Erik D. Herzog
Circadian rhythms in gene expression and hormones are ubiquitous across species and differentiated cell types, yet their developmental origins remain poorly understood. This study aimed to determine if daily rhythms can be detected in utero and if they synchronize to the mother. We developed methods to longitudinally monitor PERIOD2 (PER2), a core circadian clock protein, from embryonic day (E)8.5 to E17.5 by restricting PER2::LUCIFERASE expression to the mouse fetoplacental unit (fetus and fetal-derived tissues). In utero fetoplacental bioluminescence imaging showed that PER2 levels increased during pregnancy, with variable daily peak times that stabilized to early night by E15.5. Interestingly, pregnancies that did not exhibit daily in utero PER2 variation were more likely to fail. Because maternal glucocorticoids have been implicated in fetal development and synchronizing other circadian tissues, we tested whether glucocorticoid injections could shift fetoplacental PER2 rhythms in utero. Daily subcutaneous corticosterone injections over 5 days of late pregnancy phase-dependently shifted the fetoplacental PER2 rhythms in utero. Blocking glucocorticoid signaling in vitro reduced synchrony between maternal and fetal placenta. We conclude that in utero daily rhythms gradually develop and synchronize with the mother prior to birth, potentially through glucocorticoid signaling.

30 September 2025 in SLEEP Advances
Verified
Journal Article
Open access
RMRonald T McCarthy
Ronald T McCarthy
ERErin L Reinl
Erin L Reinl
PSPatricia K Strutz
Patricia K Strutz
PZPeinan Zhao
Peinan Zhao
AEAndrea Esparza
Andrea Esparza
SESarah K England
Sarah K England
Study Objectives: Melatonin regulates daily rhythms and is important for maintaining a healthy pregnancy. Certain socioeconomic factors may affect melatonin release. This study evaluates whether the increase in melatonin with advancing gestation is associated with social disadvantage. Methods: Data were prospectively collected from a socioeconomically diverse cohort of participants with singleton pregnancies (n = 921) at a Midwest academic center. Participants self-collected saliva every four hours over a 24-hour period once per trimester. Diurnal melatonin concentration was measured, and for each trimester, the maximum and mean diurnal melatonin concentration values were obtained. Cosinor-fitting was performed to obtain peak, mesor, and amplitude values, and melatonin profiles were also analyzed by calculating area under the curve. Participants were dichotomized by high and low social disadvantage score (SDS), and diurnal melatonin parameters were compared between participants with high and low SDS. Results: Mean diurnal melatonin concentration increased at an average rate of 0.19 pg/mL/week, and amplitude increased by 0.04 pg/mL/week. Participants with high SDS had significantly lower diurnal melatonin concentration amplitudes, means, mesors, and peaks than those with low SDS. Participants with high SDS had a 2.19 [95%CI = 1.94, 2.47] adjusted relative risk for low diurnal amplitude melatonin and had a smaller increase in diurnal melatonin amplitude over weeks of pregnancy than those with low SDS (−0.04 vs. 0.11 pg/mL/week, p<.001). Conclusions: Average salivary diurnal melatonin concentration increases across pregnancy, but the degree of increase varies among pregnant participants and is associated with social disadvantage. Statement of Significance During pregnancy, melatonin increases with gestational age and may promote placental homeostasis, fetal maturation, and uterine contractions. In this study, we evaluated whether the increase in melatonin with advancing gestation is modified by social disadvantage. We found that salivary diurnal melatonin concentration mean and amplitude increased as pregnancy progressed, but this increase was blunted or even reversed in participants with high social disadvantage scores. Future research should evaluate strategies to intervene, either via behavioral changes or pharmacologic therapy, to mitigate the negative impacts of social disadvantage on maternal melatonin rhythms.